You have 9 free searches left this month | for more free features.

nva237

Showing 1 - 21 of 21

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Renal Impairment Trial in Moscow (NVA237)

Completed
  • Renal Impairment
  • NVA237
  • Moscow, Russian Federation
    Novartis Investigative Site
Dec 16, 2020

COPD Trial in Worldwide (NVA237, Placebo, Salbutamol)

Completed
  • Chronic Obstructive Pulmonary Disease
  • NVA237
  • +2 more
  • Genk, Limburg, Belgium
  • +80 more
Jun 21, 2019

COPD Trial (NVA237, Placebo to NVA237)

Withdrawn
  • Chronic Obstructive Pulmonary Disease
  • NVA237
  • Placebo to NVA237
  • (no location specified)
Apr 19, 2017

COPD Trial in Spartanburg, Albrechtstrasse 14 (Placebo, NVA237)

Completed
  • Chronic Obstructive Pulmonary Disease
  • Placebo
  • NVA237
  • Spartanburg, South Carolina
  • +1 more
Aug 2, 2016

Pulmonary Disease, Chronic Obstructive Trial (NVA237, Tiotropium Respimat®)

Withdrawn
  • Pulmonary Disease, Chronic Obstructive
  • NVA237
  • Tiotropium Respimat®
  • (no location specified)
Aug 19, 2016

COPD: COPD Trial in Switzerland (QAB149, Placebo, NVA237)

Completed
  • Chronic Obstructive Pulmonary Disease: COPD
  • Faltigberg-Wald, ZH, Switzerland
  • +10 more
Jan 11, 2016

COPD (COPD) Trial in United States (NVA237, Long-acting beta 2-agonist (LABA), Placebo)

Completed
  • Chronic Obstructive Pulmonary Disease (COPD)
  • NVA237
  • +2 more
  • Gulf Shores, Alabama
  • +60 more
Feb 17, 2016

Asthma Trial (NVA237, Placebo to NVA237, salbutamol/ albuterol)

Withdrawn
  • Asthma
  • NVA237
  • +2 more
  • (no location specified)
Apr 10, 2015

COPD (COPD) Trial in Worldwide (QVA149, QAB149, NVA237)

Completed
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Birmingham, Alabama
  • +142 more
Mar 2, 2016

COPD Trial in Germany (NVA237, Tiotropium, Placebo to NVA237)

Completed
  • Chronic Obstructive Pulmonary Disease
  • NVA237
  • +4 more
  • Berlin, Germany
  • +13 more
Dec 19, 2014

COPD Trial in United States (NVA237, Placebo)

Completed
  • Chronic Obstructive Pulmonary Disease
  • NVA237
  • Placebo
  • Homewood, Alabama
  • +53 more
Feb 12, 2015

COPD Trial in United States (NVA237, Placebo)

Completed
  • Chronic Obstructive Pulmonary Disease
  • NVA237
  • Placebo
  • *See Various Dept.'s*, Arizona
  • +58 more
Mar 9, 2015

COPD (COPD) Trial in Worldwide (NVA237, Placebo)

Completed
  • Chronic Obstructive Pulmonary Disease (COPD)
  • NVA237
  • Placebo
  • Beijing, Beijing, China
  • +31 more
Jul 16, 2014

COPD (COPD) Trial in Worldwide (QVA149, QAB149, NVA237)

Completed
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Huntsville, Alabama
  • +94 more
Jul 13, 2015

COPD Trial in Worldwide (NVA237, Tiotropium, Placebo to tiotropium)

Completed
  • Chronic Obstructive Pulmonary Disease
  • NVA237
  • +4 more
  • Toronto, Ontario, Canada
  • +75 more
Apr 22, 2014

COPD Trial in Worldwide (QVA149, NVA237, QAB149)

Completed
  • Chronic Obstructive Pulmonary Disease
  • Feldbach, Austria
  • +25 more
Jan 16, 2014

COPD Trial in Worldwide (QVA149, NVA237, tiotropium)

Completed
  • Chronic Obstructive Pulmonary Disease
  • Birmingham, Alabama
  • +344 more
Oct 29, 2013

COPD Trial in Japan (NVA237, Tiotropium)

Completed
  • Chronic Obstructive Pulmonary Disease
  • Iizuka, Fukuoka, Japan
  • +39 more
Dec 12, 2012

COPD Trial in Vilvoorde, Rueil-Malmaison,, Tokyo (NVA237, Placebo, Tiotropium)

Completed
  • Chronic Obstructive Pulmonary Disease
  • NVA237
  • +2 more
  • Vilvoorde, Belgium
  • +2 more
May 3, 2012

COPD Trial in Worldwide (NVA237, Placebo)

Completed
  • Chronic Obstructive Pulmonary Disease
  • NVA237
  • Placebo
  • Spartanburg, South Carolina
  • +9 more
Apr 10, 2012

COPD (COPD) Trial in Denmark, Germany (NVA237, Placebo)

Completed
  • Chronic Obstructive Pulmonary Disease (COPD)
  • NVA237
  • Placebo
  • Copenhagen, Denmark
  • +3 more
Dec 27, 2007